MolNFT v1 · #7997 · protein
X-ray crystal structure analysis of the catalytic domain of the oncogene product P21H-RAS complexed with caged GTP and mant dgppnhp
1GNQ · C-H-RAS P21 protein: “X-ray crystal structure analysis of the catalytic domain of the oncogene product P21H-RAS complexed with…”. X-ray diffraction, 2 ligands (CAG, MG), 1 pocket (best druggability 0.47). MolNFT v1 #7997 on…
- PDB
- 1GNQ
- Type
- protein
- Length
- 166 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- C-H-RAS P21 protein
- UniProt
- P01112
- Ligands
- CAG, MG
- Pockets
- 1 · best druggability 0.47
Structure
x-ray diffraction · 1 distinct chain · 33% helix, 26% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | C-H-RAS P21 protein | protein | 166 | 33% helix, 26% strand | P01112 |
Ligands and binding sites
- CAG · Guanosine 5'-triphosphate P3-[1-(2-nitrophenyl)ethyl ester] · ligand · chains A
- MG · Magnesium ion · metal · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 161 | 0.47 | 0.76 | 27 | MG, CAG |
Compared structures
- 1GNQ · X-ray crystal structure analysis of the catalytic domain of the oncogene product P21H-RAS… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P01112
- Elsewhere: RCSB PDB 1GNQ · PDBe 1GNQ · UniProt P01112
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.